New Delhi (India Science Wire): Council of Scientific & Industrial Research (CSIR)’s constituent laboratories have been working relentlessly in partnership with industry to launch repurposed drugs through process development and conducting clinical trials. CSIR labs have also extensively contributed towards
The government has also initiated a study on whether Ashwagandha can be an alternative to anti-malarial drug Hydroxychloroquine (HCQ) as a potential COVID-19 preventive. Ayurvedic herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a
New Delhi(India Science Wire): India has adopted plasma therapy is some severely ill COVID- 19 patients. While plasma therapy hasn’t yet shown a benefit in randomized trials, some small retrospective studies suggest it may reduce illness severity and reduce hospitalization
